Page last updated: 2024-08-22

hafnium and Oropharyngeal Neoplasms

hafnium has been researched along with Oropharyngeal Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bernois, K; Borcoman, E; Calugaru, V; Calvo, E; Chilles, A; Dimitriu, M; Doger, B; Fakhry, N; Hee Kam, SW; Hoffmann, C; Jouffroy, T; Le Tourneau, C; Liem, X; Mirabel, X; Moreno, V; Rodriguez, J; Salas, S1

Trials

1 trial(s) available for hafnium and Oropharyngeal Neoplasms

ArticleYear
Phase I dose-escalation study of NBTXR3 activated by intensity-modulated radiation therapy in elderly patients with locally advanced squamous cell carcinoma of the oral cavity or oropharynx.
    European journal of cancer (Oxford, England : 1990), 2021, Volume: 146

    Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Follow-Up Studies; Hafnium; Humans; Male; Maximum Tolerated Dose; Nanoparticles; Non-Randomized Controlled Trials as Topic; Oropharyngeal Neoplasms; Oxides; Prognosis; Radiotherapy, Intensity-Modulated

2021